MEDICAL-TREATMENT OF MALIGNANT-MELANOMA

[1] BAJETTA E, 1978, 12 P INT CANC C BUEN

[2] BERETTA G, 1976, CANCER TREAT REP, V60, P33

[3] BERETTA G, 1978, 12 P INT CANC C BUEN

[4] BERETTA G, 1978, CHEMIOTER ONCOL, V2, P39

[5] BERETTA G, 1976, IMMUNOTHERAPY CANCER

[6] BERETTA G, 1977, 3RD ONC C INT PART B

[7] BERETTA G, 1975, 6TH REV M WHO COLL C

[8] BERETTA G, 1979, 1ST INT C HORM CANC

[9] BONADONNA G, 1975, CANCER CHEMOTH REP 3, V6, P381

[10] BONFANTE V, 1979, P AM ASSOC CANC RES, V20, P172

[1] BAJETTA E, 1978, 12 P INT CANC C BUEN

[2] BERETTA G, 1976, CANCER TREAT REP, V60, P33

[3] BERETTA G, 1978, 12 P INT CANC C BUEN

[4] BERETTA G, 1978, CHEMIOTER ONCOL, V2, P39

[5] BERETTA G, 1976, IMMUNOTHERAPY CANCER

[6] BERETTA G, 1977, 3RD ONC C INT PART B

[7] BERETTA G, 1975, 6TH REV M WHO COLL C

[8] BERETTA G, 1979, 1ST INT C HORM CANC

[9] BONADONNA G, 1975, CANCER CHEMOTH REP 3, V6, P381

[10] BONFANTE V, 1979, P AM ASSOC CANC RES, V20, P172